CAM
NEO icon

ClariVest Asset Management’s NeoGenomics NEO Stock Holding History

ClariVest Asset Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$459K Hold
33,119
– – 0.05% 356
2024
Q2 		$459K Buy
33,119
+40
+0.1% +$567 0.05% 356
2024
Q1 		$520K Buy
33,079
+87
+0.3% +$1.34K 0.05% 356
2023
Q4 		$534K Sell
32,992
-5,800
-15% -$94.9K 0.03% 356
2023
Q3 		$477K Sell
38,792
-39,371
-50% -$585K 0.03% 347
2023
Q2 		$1.25M Buy
78,163
+45,296
+138% +$746K 0.06% 200
2023
Q1 		$573K Buy
32,867
+205
+0.6% +$2.92K 0.03% 364
2022
Q4 		$302K Buy
+32,662
New +$304K 0.01% 414
2021
Q4 		– Sell
-22,489
Closed -$1.08M – 784
2021
Q3 		$1.08M Sell
22,489
-904
-4% -$41.8K 0.04% 307
2021
Q2 		$1.06M Buy
23,393
+50
+0.2% +$2.21K 0.04% 283
2021
Q1 		$1.13M Sell
23,343
-1,400
-6% -$72.9K 0.04% 271
2020
Q4 		$1.33M Sell
24,743
-33,893
-58% -$1.53M 0.05% 241
2020
Q3 		$2.16M Sell
58,636
-2,637
-4% -$98K 0.07% 214
2020
Q2 		$1.9M Sell
61,273
-1,640
-3% -$45.4K 0.05% 237
2020
Q1 		$1.74M Sell
62,913
-364
-0.6% -$10.9K 0.05% 215
2019
Q4 		$1.85M Sell
63,277
-42,785
-40% -$1.02M 0.04% 253
2019
Q3 		$2.03M Sell
106,062
-5,817
-5% -$136K 0.05% 256
2019
Q2 		$2.46M Sell
111,879
-800
-0.7% -$17.6K 0.06% 227
2019
Q1 		$2.3M Buy
112,679
+83,695
+289% +$1.45M 0.05% 300
2018
Q4 		$365K Buy
+28,984
New +$432K 0.01% 483
2017
Q2 		– Sell
-89,000
Closed -$701K – 699
2017
Q1 		$701K Buy
89,000
+900
+1% +$7.33K 0.02% 365
2016
Q4 		$754K Buy
88,100
+6,800
+8% +$58.3K 0.02% 369
2016
Q3 		$668K Buy
81,300
+1,100
+1% +$9.23K 0.02% 352
2016
Q2 		$644K Buy
+80,200
New +$643K 0.02% 335

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ClariVest Asset Management's NEO Position: Q3 2024 in Review

ClariVest Asset Management held its NeoGenomics (NEO) position steady in Q3 2024 at 33,119 shares worth $459K. The position accounts for 0.05% of the portfolio, ranked #356.

ClariVest Asset Management first reported a position in NEO in Q2 2016 and has held it in 24 quarters since. The position peaked at $2.46M in Q2 2019. 270 funds tracked by Wall St. Rank hold NEO as of Q3 2024.

  • ClariVest Asset Management held 33,119 shares of NeoGenomics worth $459K as of Q3 2024.
  • ClariVest Asset Management left its NeoGenomics share count unchanged in Q3 2024.
  • NeoGenomics made up 0.05% of ClariVest Asset Management's portfolio in Q3 2024, its #356 holding.
  • ClariVest Asset Management first reported a position in NeoGenomics in Q2 2016 and has held it in 24 quarters since.
  • ClariVest Asset Management's NeoGenomics position peaked at $2.46M in Q2 2019.
  • 270 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.